Discontinued — last reported Q2 '20
West Pharmaceutical Services Lease Liability Payments - Remainder of Fiscal Year increased by 175.0% to $1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.2%, from $900.00K to $1.10M. Over 3 years (FY 2020 to FY 2023), Lease Liability Payments - Remainder of Fiscal Year shows an upward trend with a 14.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate greater near-term cash outflows, impacting short-term liquidity and working capital.
The total cash outflows required to satisfy operating and finance lease obligations for the remaining portion of the cur...
Standard disclosure under ASC 842 lease accounting standards.
lease_liability_payments_remainder_fiscal_year| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.50M | $10.30M | $11.50M | $11.70M | $12.30M | $15.90M | $19.00M | $18.30M | $18.60M | $19.10M | $18.70M | $19.50M | $400.00K | $200.00K | $900.00K | $700.00K | $400.00K | $1.10M |
| QoQ Change | — | -1.9% | +11.7% | +1.7% | +5.1% | +29.3% | +19.5% | -3.7% | +1.6% | +2.7% | -2.1% | +4.3% | -97.9% | -50.0% | +350.0% | -22.2% | -42.9% | +175.0% |
| YoY Change | — | — | — | — | +17.1% | +54.4% | +65.2% | +56.4% | +51.2% | +20.1% | -1.6% | +6.6% | -97.8% | -99.0% | -95.4% | +75.0% | +100.0% | +22.2% |